Patent details

EP3102244 Title: ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS

Basic Information

Publication number:
EP3102244
PCT Application Number:
EP2015052341
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157057787
PCT Publication Number:
WO2015118030
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS
French Title of Invention:
CONJUGUÉS ANTICORPS-MÉDICAMENT ET IMMUNOTOXINES
German Title of Invention:
ANTIKÖRPER-ARZNEIMITTELKONJUGATE UND IMMUNTOXINE
SPC Number:

Dates

Filing date:
04/02/2015
Grant date:
18/03/2020
EP Publication Date:
14/12/2016
PCT Publication Date:
13/08/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/03/2020
EP B1 Publication Date:
18/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/02/2021
Expiration date:
04/02/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/03/2020
 
 

Name:
Oncomatryx Biopharma, S.L.
Address:
Parque Tecnológico de Bizkaia Edificio 801-B 2° planta, 48160 Derio (Vizcaya), Spain (ES)

Inventor

1

Name:
SIMON, Laureano
Address:
Spain (ES)

2

Name:
FABRE, Myriam
Address:
Spain (ES)

3

Name:
KONTERMANN, Roland
Address:
Spain (ES)

4

Name:
PFIZENMAIER, Klaus
Address:
Spain (ES)

5

Name:
FERRER, Cristina
Address:
Spain (ES)

Priority

Priority Number:
201402006
Priority Date:
06/02/2014
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
C07K 14/42; C07K 16/30; A61K 47/68;

Publication

European Patent Bulletin

Issue number:
202012
Publication date:
18/03/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages